Page 3 - Stefano Colloca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Syndicated Content By Giuseppe Fonte ROME (Reuters) – Italy’s hopes of producing its own COVID-19 vaccine have been thrown into doubt after the state audit court rejected a plan to pump public funds into local biotech company ReiThera, two sources close to the matter told Reuters on Friday. A source at the audit court said it had ruled this week against a contract drawn up by state agency Invitalia to invest some 50 million euros ($60.62 million) as part of a deal with ReiThera to support its development of the new vaccine. “The investment scheme is illegitimate,...

3 Min Read ROME (Reuters) - Italy’s hopes of producing its own COVID-19 vaccine have been thrown into doubt after the state audit court rejected a plan to pump public funds into local biotech company ReiThera, two sources close to the matter told Reuters on Friday. FILE PHOTO: A healthcare worker holds a vial of Italy's ReiThera coronavirus disease (COVID-19) vaccine as doctors at a Pisa hospital begin testing phase 2 and 3 on patients after initial positive test results, in Pisa, Italy, April 1, 2021. REUTERS/Jennifer Lorenzini/File Photo A source at the audit court said it had ruled this ...

Healthcare & PharmaceuticalsEXCLUSIVE Italy audit court rejects public funding for ReiThera COVID-19 vaccine-sources Giuseppe Fonte 1/3 A healthcare worker holds a vial of Italy's ReiThera coronavirus disease (COVID-19) vaccine as doctors at a Pisa hospital begin testing phase 2 and 3 on patients after initial positive test results, in Pisa, Italy, April 1, 2021. REUTERS/Jennifer Lorenzini/File Photo Read More Italy's hopes of producing its own COVID-19 vaccine have been thrown into doubt after the state audit court rejected a plan to pump public funds into local biotech company ReiThera, two...

Drugmakers say Joe Biden misguided over vaccine patent waiver SECTIONS Last Updated: May 07, 2021, 11:37 PM IST Share Synopsis If adopted by the World Trade Organisation, the proposal would invite new manufacturers that lack essential know-how and oversight from the inventors to crowd out established contractors, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) said. AFP Drugmakers on Thursday said U.S. President Joe Biden's support for waiving patents of COVID-19 vaccines could disrupt a fragile supply chain and that rich countries should instead share mo...

Italian officials are optimistic about ReiThera’s vaccine — if the company can secure scarce key supplies and answer ethical questions about testing.